GLP-3 RT is an investigational research peptide characterized by activity at three receptor systems: GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and glucagon receptors.
Its triple-receptor profile has made the compound a subject of scientific investigation involving multi-receptor agonism, receptor pharmacology, and incretin/glucagon signaling pathways.
GLP-3 RT has also been studied for its extended pharmacokinetic characteristics, providing researchers with a model for investigating sustained signaling across GLP-1, GIP, and glucagon receptor systems.
GLP-3 RT is an investigational research material and is not FDA-approved. For laboratory research and analytical purposes only. Not for human or animal consumption.
